PLA1A Inhibition Enhances Chemoimmunotherapy Efficacy by Blocking Immunosuppressive Macrophage Polarization in Colorectal Cancer.

Inhibiting PLA1A boosts chemoimmunotherapy effectiveness by reducing immunosuppressive M2-like macrophages in colorectal cancer, with a 50% decrease observed in murine models.

• Why it matters: Overcoming immunosuppression in colorectal cancer is critical for improving patient outcomes, as current treatments often fail due to tumor immune evasion mechanisms.
• What they did: Single-cell RNA sequencing of paired tumor samples before and after neoadjuvant chemotherapy identified increased PLA1A expression linked to M2 macrophage polarization; pharmacological inhibition with cilengitide was tested in mouse models.
• The result: Blocking PLA1A enhanced chemoimmunotherapy responses, suggesting that targeting this enzyme can mitigate immunosuppression and potentially improve clinical outcomes in colorectal cancer patients.